Vaxart Inc

NASDAQ:VXRT  
6.62
+0.32 (+5.00%)
Products

Vaxart Announces FDA Clearance Of IND Application For Oral COVID-19 Vaccine

Published: 09/14/2020 16:04 GMT
Vaxart Inc (VXRT) - Vaxart Announces FDA Clearance of Ind Application for Oral Covid-19 Vaccine and Provides Update on Covid-19 Program.
Vaxart Inc - Recruitment for Phase 1 Clinical Study Expected to Start This Month.
Vaxart Inc - Data From Two Ongoing Animal Challenge Studies Expected Starting With Mid-october.
Vaxart Inc - Phase 1, Open-label, Dose-ranging Study Will Be Conducted in Healthy Adults Ages 18 to 55 Years Old.
Vaxart Inc - Study's Primary Objective is to Examine Safety and Reactogenicity of Two-doses of Vaccine.